4:35 PM
Jan 04, 2013
 |  BC Extra  |  Financial News

Solstice secures $18 million in series A

New RNAi delivery company Solstice Biologics LLC (San Diego, Calif.) secured $18 million in a tranched series A round led by venBio. Aeris Capital is also participating. Solstice raised $3 million...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >